A pilot trial testing the feasibility of administering D-penicillamine to extremely low birth weight neonates.
OBJECTIVE: We enterally administered a 14-day course of 3-mercapto-D-valine (D-penicillamine) to five extremely low birth weight (ELBW) neonates, as a step toward assessing this therapy as a means of reducing the incidence or severity of retinopathy of prematurity (ROP). METHODS: The study drug (100...
| Publicado en: | Journal of Perinatology Vol. 26; no. 2; pp. 120 - 125 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
Feb2006
|
| Acceso en línea: | Ver este registro en EBSCOhost |